Press Releases

All News
By Year:
2019
2018
2017
2016

Dec 17, 2019

DiaMedica Therapeutics Announces First Patient Dosed in REDUX Phase II Clinical Trial of DM199 for the Treatment of Chronic Kidney Disease

Nov 13, 2019

DiaMedica Therapeutics Announces Third Quarter 2019 Financial Results and Provides Business Update

Nov 6, 2019

DiaMedica Therapeutics to Report Third Quarter 2019 Financials and Provide a Business Update November 14, 2019

Nov 5, 2019

DiaMedica Therapeutics to Participate in 10th Annual Craig-Hallum Alpha Select Conference

Oct 14, 2019

DiaMedica Therapeutics Announces Clearance to Initiate Phase II Clinical Trial of DM199 for Chronic Kidney Disease

Sep 6, 2019

DiaMedica Therapeutics to Present at Lake Street’s 3rd Annual Best Ideas Growth (BIG3) Conference on September 12, 2019

Sep 3, 2019

DiaMedica Therapeutics to Present at the 2019 Dougherty & Co. Institutional Investor Conference

Aug 13, 2019

DiaMedica Therapeutics Announces Second Quarter 2019 Financial Results and Provides Business Update

Aug 12, 2019

DiaMedica Therapeutics to Present at the 2019 Intellisight Investor Conference on August 14, 2019

Aug 8, 2019

DiaMedica Therapeutics to Report Second Quarter 2019 Financials and Provide a Business Update August 13, 2019